Normal view MARC view ISBD view

Miscellaneous Intelligence. [electronic resource]

Publication details: The Medico-chirurgical review and journal of medical science. Analytical series Dec 1823Description: 738-742 p. digital In: The Medico-chirurgical review and journal of medical science. Analytical series vol. 4

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6

1 Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis.
by Snead, Jennifer L
2 The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
by O'Hare, Thomas
3 The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile.
by Eide, Christopher A
4 Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.
by O'Hare, Thomas
5 BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
by Khorashad, Jamshid S
6 AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.
by O'Hare, Thomas

Close